| People | Locations | Statistics |
|---|---|---|
| Naji, M. |
| |
| Motta, Antonella |
| |
| Aletan, Dirar |
| |
| Mohamed, Tarek |
| |
| Ertürk, Emre |
| |
| Taccardi, Nicola |
| |
| Kononenko, Denys |
| |
| Petrov, R. H. | Madrid |
|
| Alshaaer, Mazen | Brussels |
|
| Bih, L. |
| |
| Casati, R. |
| |
| Muller, Hermance |
| |
| Kočí, Jan | Prague |
|
| Šuljagić, Marija |
| |
| Kalteremidou, Kalliopi-Artemi | Brussels |
|
| Azam, Siraj |
| |
| Ospanova, Alyiya |
| |
| Blanpain, Bart |
| |
| Ali, M. A. |
| |
| Popa, V. |
| |
| Rančić, M. |
| |
| Ollier, Nadège |
| |
| Azevedo, Nuno Monteiro |
| |
| Landes, Michael |
| |
| Rignanese, Gian-Marco |
|
Her, Tracy K.
in Cooperation with on an Cooperation-Score of 37%
Topics
Publications (2/2 displayed)
- 2021178-OR: Lipotoxicity Stimulates ß-Cell Extracellular Vesicle Secretion Which Induces ß-Cell Dysfunction and Perturbs ß-Cell Transcriptional Identity
- 2019199-OR: Time-Restricted Feeding Ameliorates Metabolic Dysfunction through the Restoration of Circadian Beta-Cell Function and Transcriptional Identity
Places of action
| Organizations | Location | People |
|---|
article
178-OR: Lipotoxicity Stimulates ß-Cell Extracellular Vesicle Secretion Which Induces ß-Cell Dysfunction and Perturbs ß-Cell Transcriptional Identity
Abstract
<jats:p>Chronically elevated circulating free fatty acids (FFA) contribute to β-cell dysfunction and thus to the onset of obesity-driven type 2 diabetes (T2DM). Prolonged β-cell exposure to FFA is associated with reduced glucose-stimulated insulin secretion (GSIS), alterations in β-cell transcriptional identity, and apoptosis. However, the mechanisms that contribute to the demise of β-cells under lipotoxic conditions have yet to be fully elucidated. Increasing evidence suggests that aberrant release of extracellular vesicles (EV) contribute to the pathogenesis of β-cell failure in T2DM. However, what remains to be deciphered is the role of β-cell-derived EV in lipotoxicity-mediated β-cell failure. We set out to test the hypothesis that lipotoxicity-mediated β-cell dysfunction is mediated in part by paracrine release of ‘toxic’ β-cell-derived EV. To address this, MIN6 β-cells were exposed to palmitate (0.5 mM, 24h) and EV were isolated using differential ultracentrifugation to yield palmitate (PAL) EV (vs. control (CTL) EV). Nanoparticle Tracking Analysis (NTA) revealed a significant increase in PAL EV concentration (~1.5 fold vs. CTL EV) with a reduction in average particle size (CTL EV = 121 nm vs. PAL EV = 75 nm). β-cell functional assessment of mouse islets exposed to PAL EV (48h) resulted in significant suppression of GSIS (~3.4 fold decrease in stimulation index). Global transcriptomic analysis was assessed using RNA-Seq on islets exposed to PAL EV. Over 900 genes were differentially upregulated and ~450 genes downregulated upon PAL EV exposure (p&lt;.05, FC&gt;1.5). Genes upregulated with PAL EV encoded for KEGG pathways regulating protein digestion/absorption, ECM-receptor interaction, and PI3K/Akt signaling, while downregulated genes encode for pathways regulating glycolysis and protein processing in ER (FDR&lt;.05). These data suggest the novel relevance of β-cell-derived EV in free fatty acid-induced β-cell failure in T2DM.</jats:p><jats:sec><jats:title>Disclosure</jats:title><jats:p>T. K. Her: None. M. Brown: None. A. Matveyenko: None. N. Javeed: None.</jats:p></jats:sec><jats:sec><jats:title>Funding</jats:title><jats:p>National Institutes of Health (R01DK098468, T32HL105355)</jats:p></jats:sec>